GM-CSF Promotes the Survival of Peripheral-Derived Myeloid Cells in the Central Nervous System for Pain-Induced Relapse of Neuroinflammation
The Journal of Immunology · 01.07.2023 · 211 (1) · 34-42
DOI: 10.4049/jimmunol.2200567 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Immunology, online erschienen am 22.05.2023. Verfasst von Shiina Matsuyama und 22 weiteren Autor:innen. Beteiligte Einrichtung: Division of Molecular Psychoimmunology, Institute for Genetic Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan. Hauptthemen laut MEDLINE: Encephalomyelitis, Autoimmune, Experimental, Multiple Sclerosis. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 29 Literaturangaben. Gefördert von: Kakennhi, AMED.
Abstract (Originalsprache)
We recently discovered a (to our knowledge) new neuroimmune interaction named the gateway reflex, in which the activation of specific neural circuits establishes immune cell gateways at specific vessel sites in organs, leading to the development of tissue-specific autoimmune diseases, including a multiple sclerosis (MS) mouse model, experimental autoimmune encephalomyelitis (EAE). We have reported that peripheral-derived myeloid cells, which are CD11b+MHC class II+ and accumulate in the fifth lumbar (L5) cord during the onset of a transfer model of EAE (tEAE), play a role in the pain-mediated relapse via the pain-gateway reflex. In this study, we investigated how these cells survive during the remission phase to cause the relapse. We show that peripheral-derived myeloid cells accumulated in the L5 cord after tEAE induction and survive more than other immune cells. These myeloid cells, which highly expressed GM-CSFRα with common β chain molecules, grew in number and expressed more Bcl-xL after GM-CSF treatment but decreased in number by blockade of the GM-CSF pathway, which suppressed pain-mediated relapse of neuroinflammation. Therefore, GM-CSF is a survival factor for these cells. Moreover, these cells were colocalized with blood endothelial cells (BECs) around the L5 cord, and BECs expressed a high level of GM-CSF. Thus, GM-CSF from BECs may have an important role in the pain-mediated tEAE relapse caused by peripheral-derived myeloid cells in the CNS. Finally, we found that blockade of the GM-CSF pathway after pain induction suppressed EAE development. Therefore, GM-CSF suppression is a possible therapeutic approach in inflammatory CNS diseases with relapse, such as MS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Molecular Psychoimmunology, Institute for Genetic Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan.
- Department of Orthopaedic Surgery, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan.
- Group of Quantum Immunology, Institute for Quantum Life Science, National Institute for Quantum and Radiological Science and Technology, Inage, Japan.
- Laboratory of Histology and Cytology, Graduate School of Medicine, Hokkaido University, Sapporo, Japan.
- Department of Rheumatology, Endocrinology and Nephrology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan.
- Department of Dentistry, Tsurumi University, Yokohama, Japan.
ORCID-Profile: Shiina Matsuyama, Rieko Nishi, Junko Nio-Kobayashi, Nobuya Abe, Jing-Jing Jiang, Toshihiko Iwanaga, Izuru Ohki, Shintaro Hojyo, Rie Hasebe, Shimpei I Kubota, Masaaki Murakami
Förderung
- Kakennhi
- AMED
Zitieren
APA
Matsuyama, S., Yamamoto, R., Murakami, K., Takahashi, N., Nishi, R., Ishii, A., Nio-Kobayashi, J., Abe, N., Tanaka, K., Jiang, J. J., Kawamoto, T., Iwanaga, T., Shinohara, Y., Yamasaki, T., Ohki, I., Hojyo, S., Hasebe, R., Kubota, S. I., Hirata, N., …, & Murakami, M. (2023). GM-CSF Promotes the Survival of Peripheral-Derived Myeloid Cells in the Central Nervous System for Pain-Induced Relapse of Neuroinflammation. The Journal of Immunology, 211(1), 34-42. https://doi.org/10.4049/jimmunol.2200567
Vancouver
Matsuyama S, Yamamoto R, Murakami K, Takahashi N, Nishi R, Ishii A, et al. GM-CSF Promotes the Survival of Peripheral-Derived Myeloid Cells in the Central Nervous System for Pain-Induced Relapse of Neuroinflammation. The Journal of Immunology. 2023;211(1):34-42. doi:10.4049/jimmunol.2200567
BibTeX
@article{Matsuyama2023,
author = {Matsuyama, Shiina and Yamamoto, Reiji and Murakami, Kaoru and Takahashi, Nobuhiko and Nishi, Rieko and Ishii, Asuka and Nio-Kobayashi, Junko and Abe, Nobuya and Tanaka, Kumiko and Jiang, Jing-Jing and Kawamoto, Tadafumi and Iwanaga, Toshihiko and Shinohara, Yuta and Yamasaki, Takeshi and Ohki, Izuru and Hojyo, Shintaro and Hasebe, Rie and Kubota, Shimpei I and Hirata, Noriyuki and Kamimura, Daisuke and Hashimoto, Shigeru and Tanaka, Yuki and Murakami, Masaaki},
title = {GM-CSF Promotes the Survival of Peripheral-Derived Myeloid Cells in the Central Nervous System for Pain-Induced Relapse of Neuroinflammation},
journal = {The Journal of Immunology},
year = {2023},
volume = {211},
number = {1},
pages = {34--42},
doi = {10.4049/jimmunol.2200567}
}
EUVIMED